Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.
Adenoma
/ genetics
Adolescent
Adult
Aged
Chromogranins
/ genetics
Comparative Genomic Hybridization
DNA Methylation
Female
GTP-Binding Protein alpha Subunits, Gs
/ genetics
Gene Expression Regulation, Neoplastic
Glucose
/ metabolism
Growth Hormone
/ metabolism
Growth Hormone-Secreting Pituitary Adenoma
/ genetics
Humans
Insulin-Like Growth Factor I
/ metabolism
Male
Middle Aged
Phenotype
Receptors, Gastrointestinal Hormone
/ genetics
Young Adult
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 05 2019
01 05 2019
Historique:
received:
11
07
2018
accepted:
23
10
2018
pubmed:
31
10
2018
medline:
25
2
2020
entrez:
31
10
2018
Statut:
ppublish
Résumé
Besides GNAS gene mutations, the molecular pathogenesis of somatotroph adenomas responsible for gigantism and acromegaly remains elusive. To investigate alternative driver events in somatotroph tumorigenesis, focusing on a subgroup of acromegalic patients with a paradoxical increase in growth hormone (GH) secretion after oral glucose, resulting from ectopic glucose-dependent insulinotropic polypeptide receptor (GIPR) expression in their somatotropinomas. We performed combined molecular analyses, including array-comparative genomic hybridization, RNA/DNA fluorescence in situ hybridization, and RRBS DNA methylation analysis on 41 somatotropinoma samples from 38 patients with acromegaly and three sporadic giants. Ten patients displayed paradoxical GH responses to oral glucose. GIPR expression was detected in 13 samples (32%), including all 10 samples from patients with paradoxical GH responses. All GIPR-expressing somatotropinomas were negative for GNAS mutations. GIPR expression occurred through transcriptional activation of a single allele of the GIPR gene in all GIPR-expressing samples, except in two tetraploid samples, where expression occurred from two alleles per nucleus. In addition to extensive 19q duplications, we detected in four samples GIPR locus microamplifications in a certain proportion of nuclei. We identified an overall hypermethylator phenotype in GIPR-expressing samples compared with GNAS-mutated adenomas. In particular, we observed hypermethylation in the GIPR gene body, likely driving its ectopic expression. We describe a distinct molecular subclass of somatotropinomas, clinically revealed by a paradoxical increase of GH to oral glucose related to pituitary GIPR expression. This ectopic GIPR expression occurred through hypomorphic transcriptional activation and is likely driven by GIPR gene microamplifications and DNA methylation abnormalities.
Identifiants
pubmed: 30376114
pii: 5145119
doi: 10.1210/jc.2018-01504
doi:
Substances chimiques
Chromogranins
0
IGF1 protein, human
0
Receptors, Gastrointestinal Hormone
0
Insulin-Like Growth Factor I
67763-96-6
Growth Hormone
9002-72-6
gastric inhibitory polypeptide receptor
D6H00MV7K8
GNAS protein, human
EC 3.6.1.-
GTP-Binding Protein alpha Subunits, Gs
EC 3.6.5.1
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1777-1787Informations de copyright
Copyright © 2019 Endocrine Society.